Global Duchenne Muscular Dystrophy Therapeutics Market to hit $ 6.64 billion by 2033 with Gene Therapy innovations
Rising approvals of exon-skipping, gene, and RNA-based therapies, combined with strategic partnerships, are driving robust global DMD market growth. AUSTIN, TX, UNITED STATES, October 13, 2025 /EINPresswire.com/ -- DataM Intelligence reports …